ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeted nitric oxide delivery preferentially induces glioma cell chemosensitivity via altered p53 and O6-Methylguanine-DNA Methyltransferase activity

Safdar S; Payne C A; Tu N H; Taite L J*georgia institute of technology
Biotechnology and Bioengineering2013DOI: 10.1002/bit.24775
5阅读
引用收藏
分享

摘要

Glioblastoma multiforme is the most common malignant central nervous system tumor, and also among the most difficult to treat due to a lack of response to chemotherapeutics. New methods of countering the mechanisms that confer chemoresistance to malignant gliomas could lead to significant advances in the quest to identify novel drug combinations or targeted drug delivery systems for cancer therapy. In this study, we investigate the use of a targeted nitric oxide (NO) donor as a pretreatment to sensitize glioma cells to chemotherapy. The protein chlorotoxin (CTX) has been shown to preferentially target glioma cells, and we have developed CTX-NO, a glioma-specific, NO-donating CTX derivative. Pretreatment of cells with CTX-NO followed by 48-h exposure to either carmustine (BCNU) or temozolomide (TMZ), both common chemotherapeutics used in glioma treatment, resulted in increased efficacy of both therapeutics. After CTX-NO exposure, both T98G and U-87MG human malignant glioma cells show increased sensitivity to BCNU and TMZ. Further investigation revealed that the consequences of this combination therapy was a reduction in active levels of the cytoprotective enzyme MGMT and altered p53 activity, both of which are essential in DNA repair and tumor cell resistance to chemotherapy. The combination of CTX-NO and chemotherapeutics also led to decreased cell invasion. These studies indicate that this targeted NO donor could be an invaluable tool in the development of novel approaches to treat cancer.

学科与关键词

关键词
Glioblastoma, chemosensitivityNitric oxideNitric oxide donorTargeted drug delivery
相关
加载中…
  • Glioma cell membrane camouflaged cinobufotalin delivery system for combinatorial orthotopic glioblastoma therapy
    Song, Zibin; Zhao, Liqian; Fang, Weiyi; Guo, Siyun; Xu, Anqi; Zhan, Zhengming; Cai, Yonghua; Xue, ShuaiShuai; Chai, Peng; Jiang, Qiuhua*; Zhao, Peng*; Song, Ye*Nano Research, 2023, 16(8): 11164-11175.
  • Manganese Dioxide-Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief
    Jiang, Shuqi; Li, Xiaohu; Zhang, Fang; Mao, Jiaji; Cao, Minghui; Zhang, Xinna; Huang, Siming; Duan, Xiaohui*; Shen, Jun*Small Methods, 2022, 6(7): 2101531.被引 15
  • Enhanced Efficacy of Temozolomide Loaded by Tetrahedral Framework DNA Nanoparticle in Therapy for Glioblastoma.
    Fu Wei; You Chao; Ma Lu; Li Hao; Ju Yan; Guo Xi; Shi Sirong; Zhang Tao; Zhou Ronghui; Lin Yunfeng2019.
查看全部 →

发表信息

论文状态
公开发表
期刊
Biotechnology and Bioengineering
发表日期
2013
卷期
第 110 卷, 第 4 期
页码
1211-1220
DOI
10.1002/bit.24775
语言
ENGLISH
期刊等级
Q1
成果收录
SCOPUS

作者

  • S

    Safdar S (第一作者)

    georgia institute of technology

  • P

    Payne C A

查看全部 4 位作者收起作者
  • T

    Tu N H

    georgia institute of technology

  • T

    Taite L J (通讯)

    georgia institute of technology

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417